Abiomed (ABMD) Tops Q1 EPS by 19c

Abiomed (NASDAQ: ABMD) reported Q1 EPS of $1.25, $0.19 better than the analyst estimate of $1.06. Revenue for the quarter came in at $277 million versus the consensus estimate of $278.98 million.

For earnings history and earnings-related data on Abiomed (ABMD) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Innovative Solutions & Support (ISSC) Tops Q3 EPS by 10c
• Pulmatrix (PULM) Reports Q2 Loss of $0.29